Loading stock data…
CL
$87.80+1.73 (+2.01%)
After Hours$87.80+0.00 (+0.00%)· Last close Jun 9
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Colgate-Palmolive Company in the Consumer Defensive sector is trading at $87.80. Wall Street consensus targets $95.84 (19 analysts), implying a +9.2% move over the next 12 months. The stock is currently 12% below its 52-week high of $99.33, remaining 5.2% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +9.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$87.80
Potential Downside
0%
Whystock Fair Value$87.80
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus19 analysts
Buy
Mean target$95.84+9.2%
Range$80.00 – $105.00
Fundamentals
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Ho...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Strong income play. Yield provides a meaningful total return floor.
2.38%
ROE
Elite ROE. Management converts capital into profit efficiently.
1439.31%
Volume
Today's trading volume
5.38M
Recent News
OLLI or CL: Which Is the Better Value Stock Right Now?
OLLI vs. CL: Which Stock Is the Better Value Option?
Israel retaliates against Iran after weekend attacks; Trump urges restraint
Investing.com -- Israel attacked Iranian military targets after Tehran launched scores of missile attacks against the country on Sunday, marking a resurgence in direct hostilities between the two amid diminishing hopes for a peace deal.
Trump promises support for farmers as fuel, fertilizer costs remain elevated
Investing.com -- President Donald Trump said U.S. farmers will see "very good things" happen over the next 90 days as he sought to reassure the agricultural sector amid elevated fuel and fertilizer costs linked to the conflict with Iran, according to a Bloomberg report.
OPEC crude output drops to lowest level in 37 years
Investing.com -- OPEC crude production fell in May to its lowest level in at least 37 years as a US blockade of Iran and disruptions in the Persian Gulf continued to limit output, according to a Bloomberg survey released Friday.
Equity returns likely to moderate, but dips remain buying opportunities: GS
Investing.com -- Goldman Sachs said equity returns are likely to moderate following a sharp rally but maintained an overweight stance on stocks over a 12-month horizon, telling investors they should buy any pullbacks in the coming months.